偏向的GPR84激动剂和对生物控制的见解
Vincent B Luscombe1, Pinqi Wang2, Angela J Russell2,3
1Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
British journal of pharmacology
|December 27, 2023
概括
G蛋白结合受体84 (GPR84) 在天生的免疫力中起作用,特别是在巨细胞和中性粒细胞中. 研究探索其激动剂及其对免疫细胞的影响,旨在了解其生理功能.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- G蛋白结合受体84 (GPR84) 是一个孤儿受体,于2001年被发现.
- GPR84mRNA在先天性免疫细胞中表达高,包括M1极化巨细胞和中性粒细胞.
- 最初识别的配体是中链脂肪酸 (9-12个碳元素);合成激动剂已经开发出来.
研究的目的:
- 审查GPR84激动剂对先天性免疫细胞的影响.
- 讨论2001年以来与GPR84相关的化学发现.
- 要突出使用偏向激动剂在探测GPR84功能.
主要方法:
- 关于GPR84激动剂和先天性免疫细胞的研究文献综述.
- 分析了放射性连体结合试验和分子建模数据.
- 检查现场定向突变发生研究的结果.
主要成果:
- 已经确定了GPR84的多种合成激动剂.
- 结合的结合研究表明,GPR84受体上有三个不同的结合位点.
- 偏差激动剂已被证明对GPR84功能的体外研究有用.
结论:
- 对GPR84的生理激动剂仍然难以捉摸.
- 需要进一步的研究,以将偏向信号效应与体内先天免疫细胞功能相关联.
- 了解GPR84信号对于推进先天性免疫研究至关重要.
更多相关视频
08:46A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors
Published on: December 2, 2022
2.3K
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
13.7K
相关概念视频
G Protein-coupled Receptors
12.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.1K
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K
Transducer Mechanism: G Protein–Coupled Receptors
2.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.0K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
